$2,872.44 travel Payment -- Merck & Co to Dr. Karen Harris
Merck & Co. covers $2,872.44 in travel and lodging for Cardiology specialist Dr. Karen Harris.
This page provides a detailed analysis of a $2,872.44 travel payment from Merck & Co to Dr. Karen Harris. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $2,872.44 |
| Payment Type | travel |
| Payment Nature | Travel and Lodging |
| Pharmaceutical Company | Merck & Co |
| Physician | Dr. Karen Harris |
| NPI Number | 1013054823 |
| Physician Specialty | Cardiology |
| Location | City, WI |
| Date of Payment | 2025-06-17 |
| Conflict Assessment | Moderate -- Worth Noting |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Merck & Co made a $2.9K travel payment to Karen Harris, a Cardiology specialist in City, WI. Merck & Co. paid $2,872.44 for travel and lodging expenses to Dr. Karen Harris, a cardiologist. The payment was made on June 17, 2025, and is categorized under 'Travel and Lodging'. This record pertains to a single payment event identified by payment ID OP-MNHLXAA5-UEX4OZ.
Patient Guidance: What This Payment Means for You
This payment covers travel and lodging expenses, which may be related to educational events or professional development. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
Payments for travel and lodging to cardiologists are common, often associated with medical conferences and educational programs.
Regulatory Context: Sunshine Act Requirements
This payment falls under the Sunshine Act's reporting requirements for payments made by manufacturers of drugs, devices, and biologics to physicians and teaching hospitals.
Related Topics
This payment is related to the following healthcare transparency topics:
- pharmaceutical-payments
- travel-and-lodging
- cardiologist
- merck-co
- open-payments
- physician-payments
Understanding travel Payments
Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.
Frequently Asked Questions About This Payment
What was this $2.9K payment for?
This was a travel payment of $2.9K from Merck & Co to Karen Harris, categorized as "Travel and Lodging". The payment was reported under the Sunshine Act (CMS Open Payments).
Does Karen Harris accept pharmaceutical money?
Yes, Karen Harris received this $2.9K payment from Merck & Co. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Karen Harris's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this travel payment?
A travel payment of $2.9K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Cardiology?
To compare this payment against Cardiology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Cardiology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Karen Harris's relationship with Merck & Co?
The payment amount is specific and covers travel and lodging, suggesting a conference or educational event. This $2.9K travel payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Cardiology?
Dr. Harris's specialty is Cardiology, which is a common area for pharmaceutical company engagement.
What should patients do after learning about this payment?
This payment covers travel and lodging expenses, which may be related to educational events or professional development.
What else should I know about this travel payment?
The payment date is in the future, indicating this might be a pre-approved expense or a future event.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.